These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28144654)

  • 21. Investigations on the oxygen dependence of a 2-oxoglutarate histone demethylase.
    Sánchez-Fernández EM; Tarhonskaya H; Al-Qahtani K; Hopkinson RJ; McCullagh JS; Schofield CJ; Flashman E
    Biochem J; 2013 Jan; 449(2):491-6. PubMed ID: 23092293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Jumonji Histone Demethylase Inhibitor JIB-04 as a Broad-Spectrum Antifungal Agent.
    Wang T; Yang W; Liu Y; Li W; Wang Y; Liu N; Sheng C
    ACS Infect Dis; 2022 Jul; 8(7):1316-1323. PubMed ID: 35695031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
    Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
    J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the histone demethylase KDM4A in cancer.
    Guerra-Calderas L; González-Barrios R; Herrera LA; Cantú de León D; Soto-Reyes E
    Cancer Genet; 2015 May; 208(5):215-24. PubMed ID: 25633974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A scintillation proximity assay for histone demethylases.
    Yu W; Eram MS; Hajian T; Szykowska A; Burgess-Brown N; Vedadi M; Brown PJ
    Anal Biochem; 2014 Oct; 463():54-60. PubMed ID: 25010373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular recognition of H3/H4 histone tails by the tudor domains of JMJD2A: a comparative molecular dynamics simulations study.
    Ozboyaci M; Gursoy A; Erman B; Keskin O
    PLoS One; 2011 Mar; 6(3):e14765. PubMed ID: 21464980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase.
    Couture JF; Collazo E; Ortiz-Tello PA; Brunzelle JS; Trievel RC
    Nat Struct Mol Biol; 2007 Aug; 14(8):689-95. PubMed ID: 17589523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic features of the JMJD2A histone demethylase in breast cancer.
    Berry WL; Shin S; Lightfoot SA; Janknecht R
    Int J Oncol; 2012 Nov; 41(5):1701-6. PubMed ID: 22948256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dioxygen Binding in the Active Site of Histone Demethylase JMJD2A and the Role of the Protein Environment.
    Cortopassi WA; Simion R; Honsby CE; França TC; Paton RS
    Chemistry; 2015 Dec; 21(52):18869. PubMed ID: 26663343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting lysine specific demethylase 4A (KDM4A) tandem TUDOR domain - A fragment based approach.
    Upadhyay AK; Judge RA; Li L; Pithawalla R; Simanis J; Bodelle PM; Marin VL; Henry RF; Petros AM; Sun C
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1708-1713. PubMed ID: 29691138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ETS transcription factor ERG cooperates with histone demethylase KDM4A.
    Kim TD; Shin S; Janknecht R
    Oncol Rep; 2016 Jun; 35(6):3679-88. PubMed ID: 27109047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases.
    Li X; Moon G; Shin S; Zhang B; Janknecht R
    Mol Med Rep; 2018 Apr; 17(4):5518-5527. PubMed ID: 29393482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNF8- and RNF168-dependent degradation of KDM4A/JMJD2A triggers 53BP1 recruitment to DNA damage sites.
    Mallette FA; Mattiroli F; Cui G; Young LC; Hendzel MJ; Mer G; Sixma TK; Richard S
    EMBO J; 2012 Apr; 31(8):1865-78. PubMed ID: 22373579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of PKF118-310 as a KDM4A inhibitor.
    Franci G; Sarno F; Nebbioso A; Altucci L
    Epigenetics; 2017 Mar; 12(3):198-205. PubMed ID: 27767379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A.
    Gu R; Kim TD; Song H; Sui Y; Shin S; Oh S; Janknecht R
    JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37870957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering human JMJD2A tudor domains for an improved understanding of histone peptide recognition.
    Parkinson J; Hard R; Ainsworth R; Wang W
    Proteins; 2023 Jan; 91(1):32-46. PubMed ID: 35927178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The histone demethylase JMJD2A/KDM4A links ribosomal RNA transcription to nutrients and growth factors availability.
    Salifou K; Ray S; Verrier L; Aguirrebengoa M; Trouche D; Panov KI; Vandromme M
    Nat Commun; 2016 Jan; 7():10174. PubMed ID: 26729372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone Demethylases.
    Roatsch M; Hoffmann I; Abboud MI; Hancock RL; Tarhonskaya H; Hsu KF; Wilkins SE; Yeh TL; Lippl K; Serrer K; Moneke I; Ahrens TD; Robaa D; Wenzler S; Barthes NPF; Franz H; Sippl W; Lassmann S; Diederichs S; Schleicher E; Schofield CJ; Kawamura A; Schüle R; Jung M
    ACS Chem Biol; 2019 Aug; 14(8):1737-1750. PubMed ID: 31287655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reader domain specificity and lysine demethylase-4 family function.
    Su Z; Wang F; Lee JH; Stephens KE; Papazyan R; Voronina E; Krautkramer KA; Raman A; Thorpe JJ; Boersma MD; Kuznetsov VI; Miller MD; Taverna SD; Phillips GN; Denu JM
    Nat Commun; 2016 Nov; 7():13387. PubMed ID: 27841353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of histone demethylase JMJD1C attenuates cardiac hypertrophy and fibrosis induced by angiotensin II.
    Zhang S; Lu Y; Jiang C
    J Recept Signal Transduct Res; 2020 Aug; 40(4):339-347. PubMed ID: 32122211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.